ASLAN Pharmaceuticals (ASLN) Stock Dips 25%: What’s Your Next Step?

ASLAN Pharmaceuticals (ASLN) stock was trading at $2.6600 with small volatility starting from August 25 till August 31. However, ASLN sharply increased to $3.0550 on September 2 and it is still fluctuating at that level. The market capitalization of the shares is more than $226.256 million and the day’s range is approximately $3.1200 – $3.3599. Today, ASLAN Pharmaceuticals Limited made an announcement about the positive results from the randomized, double-blind, placebo-controlled, 8-week, multiple-ascending-dose  Phase 1 research of ASLAN004 which is used for the treatment of average-to-severe atopic dermatitis.

It was proved that the ASLAN004 is considered as the first potential in class monoclonal antibody which is focused on the IL-13 receptor and it is showing a good result in the tolerance in all different doses. The result of the research strongly approves the big potential of the ASLAN004 in the treatment of atopic dermatitis. In March 2021, the company reported the interim information from the three doses and then continued the treatments. 

Agneta Johansen

Agneta is still enjoying her trips to Asia and Africa while she works at Own Snap as an author and reporter. Very soon she will settle somewhere in Europe and run her startup enterprise.